Interestingly, although GR antagonism has been shown to effectively reduce drinking during the protracted abstinence period when expression of GR is elevated, the same antagonist can also be administered prior to the onset of alcohol dependence and prevent escalated intake, when presumably no changes in GR expression have yet taken place (Vendruscolo et al., 2012). The gene discussed is NR3C1; the disease is alcohol dependence.